arrow
C

Caroline Laheurte

universite marie et louis pasteur and efs and inserm
H指数:23
被引数:1,655

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multidimensional immune profiling uncovers biphasic peripheral T-cell dynamics after chemoradiation in patients with locally advanced head and neck cancer

多维免疫谱分析揭示了局部晚期头颈癌患者化疗放疗后外周T细胞呈现双相动态变化。

2026-02-260
OA
A PHASE II STUDY OF AN ANTI-TERT VACCINE (UCPVAX) WITH OR WITHOUT TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA

一项针对新诊断胶质母细胞瘤的II期研究,研究一种抗TERT疫苗(UCPVAX),单独使用或与替莫唑胺联用。

2025-10-010
OAAI
UCPVax, a CD4 helper peptide vaccine, induces polyfunctional Th1 cells, antibody response, and epitope spreading to improve antitumor immunity

UCPVax,一种CD4辅助肽疫苗,可诱导多效性Th1细胞、抗体反应以及表位扩散,以增强抗肿瘤免疫。

2025-06-200
OAAI
TIE-2–Expressing Monocytic Myeloid-Derived Suppressor Cells Are Involved in Resistance to Anti–PD-1 Therapy Mediated by Angiopoietin 2 in Patients with Melanoma

TIE-2–表达的单核髓源性抑制细胞通过Angiopoietin 2参与黑色素瘤患者对PD-1抑制疗法产生抗性。

2025-03-180
PRE
UCPVAX-GLIO: A PHASE II TRIAL EVALUATING THE IMMUNOGENICITY AND EFFICACY OF AN ANTI-TELOMERASE VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GBM
2023-09-080
OA
First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial

一线durvalumab和tremelimumab联合化疗治疗RAS突变的转移性结直肠癌: 1b/2期试验

2023-08-1034
OAAI
Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
2021-08-1096
OAAI
New Insights on End-Stage Renal Disease and Healthy Individual Gut Bacterial Translocation: Different Carbon Composition of Lipopolysaccharides and Different Impact on Monocyte Inflammatory Response
2021-06-078
OAAI
PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapy

PD-1和TIGIT共表达确定了预测anti-PD-1治疗反应的循环CD8 T细胞亚群

2020-11-1350
OAAI
PD-1 and TIGIT co-expression identifies a circulating CD8 T cell population predictive of response to anti-PD-1 therapy in melanoma and Merkel-cell carcinoma patients
2020-08-150
PRE